{"SPADE_N_15379": {"Sequence Information": {"Peptide Name": "PM181110", "Sequence": "CC", "Sequence Length": 2, "Biological Activity": ["Anticancer"], "Source": "1. Phomopsis glabrae", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Anticancer activity of new depsipeptide compound isolated from an endophytic fungus.", "Pubmed ID": "24824817", "Reference": "J Antibiot (Tokyo). 2014;67:697-701", "Author": "Verekar SA, Mishra PD, Sreekumar ES, Deshmukh SK, Fiebig HH, Kelter G, Maier A", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24824817"}], "Mass": 224.3, "PI": 5.51, "Net Charge": 0, "Hydrophobicity": 2.5, "Frequent Amino Acids": "C", "Absent Amino Acids": "ADEFGHIKLMNOPQRSTUVWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 0, "Positive Residues": 0, "Negative Residues": 0, "SPADE ID": "SPADE_N_15379", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00001", "Similarity": 1.0, "Sequence": "GSGVIPTISHECHMNSFQFVFTCCS"}, {"SPADE_ID": "SPADE_N_00005", "Similarity": 1.0, "Sequence": "GNGVIKTISHECHMNTWQFIFTCCS"}, {"SPADE_ID": "SPADE_N_00012", "Similarity": 1.0, "Sequence": "GNGVVLTLTHECNLATWTKKLKCC"}], "Hemolytic Activity": "", "Target Organism": "Human bladder cancer BXF 1352L(IC50=0.103µM),Human bladder carcinoma T24(IC50=0.05µM),Human colon adenocarcinoma HCT 116(IC50=0.048µM),Human colon adenocarcinoma HT29(IC50=0.137µM),Human colon adenocarcinoma RKO(IC50=0.074µM),Human gastric cancer GXF 251 L(IC50=0.093µM),Human head and neck cancer HNXF CAL 27(IC50=0.039µM),Human liver carcinoma LIXF 575L(IC50=0.295µM),Human lung carcinoma NCI-H460(IC50=0.146µM),Human lung carcinoma LXFA 289L(IC50=0.04µM),Human breast adenocarcinoma MCF-7(IC50=0.276µM),Human breast adenocarcinoma MDA-MB-231(IC50=0.09µM),Human melanoma MEXF 462NL(IC50=0.149µM),Human melanoma MEXF 276L(IC50=0.09µM),Human ovarian adenocarcinoma SK-OV-3(IC50=0.195µM),Human pancreatic carcinoma Panc-1(IC50=0.059µM),Human prostate cancer DU145(IC50=0.052µM),Human prostate adenocarcinoma LNCaP(IC50=0.122µM),Human prostate adenocarcinoma PC-3(IC50=0.047µM),Human pleural mesothelioma PXF 1752L(IC50=0.187µM),Human renal cancer RXF 393(IC50=0.323µM),Human renal cancer RXF 486L(IC50=0.159µM),Human rhabdomyosarcoma TE671(IC50=0.082µM),Human osteosarcoma SaOS(IC50=0.165µM),Human uterus carcinoma UXF1138L(IC50=0.126µM)"}}}